<DOC>
	<DOC>NCT00402259</DOC>
	<brief_summary>The purpose of this study is to assess the efficacy and safety of Esomeprazole and Omeprazole intravenous every 12 hours for 5 days in subjects with acute non-variceal upper gastrointestinal bleeding</brief_summary>
	<brief_title>Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute Non-Variceal Upper Gastrointestinal Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Male or female aged 1865 years. GI bleeding or with such signs within 48 hours as judged by the investigator as to have nonvariceal upper GI bleeding. One endoscopically confirmed bleeding peptic ulcer or erosive gastritis GI bleeding caused by Esophageal varices Mallory Weiss syndrome ZollingerEllison syndrome Suspicion of gastric malignancy at baseline endoscopy PostBillrothresection Unknown source of GI bleeding Â· 2.Unstable vital signs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>acute non-variceal upper gastrointestinal bleeding</keyword>
</DOC>